Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

Holley Inc. (HLLY) Q2 Earnings and Revenues Top Estimates
Holley Inc. (HLLY) Q2 Earnings and Revenues Top Estimates

Holley Inc. (HLLY) came out with quarterly earnings of $0.2 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.09 per share a year ago. These figures

Gilat Satellite (GILT) Tops Q2 Earnings Estimates
Gilat Satellite (GILT) Tops Q2 Earnings Estimates

Gilat Satellite (GILT) came out with quarterly earnings of $0.2 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.21 per share a year ago. These

EVgo Inc. (EVGO) Reports Q2 Loss, Tops Revenue Estimates
EVgo Inc. (EVGO) Reports Q2 Loss, Tops Revenue Estimates

EVgo Inc. (EVGO) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.2. This compares to a loss of $0.1 per share a year ago. These figures are

Geron (GERN) Reports Q2 Loss, Beats Revenue Estimates
Geron (GERN) Reports Q2 Loss, Beats Revenue Estimates

Geron (GERN) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.02 per share a year ago. These figures are

EyePoint (EYPT) Reports Q2 Loss, Beats Revenue Estimates
EyePoint (EYPT) Reports Q2 Loss, Beats Revenue Estimates

EyePoint (EYPT) came out with a quarterly loss of $1.09 per share versus the Zacks Consensus Estimate of a loss of $0.92. This compares to a loss of $0.85 per share a year ago. These figures are

Extreme Networks (EXTR) Q4 Earnings and Revenues Beat Estimates
Extreme Networks (EXTR) Q4 Earnings and Revenues Beat Estimates

Extreme Networks (EXTR) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.25 per share a year ago. These

Bioventus (BVS) Q2 Earnings Meet Estimates
Bioventus (BVS) Q2 Earnings Meet Estimates

Bioventus (BVS) came out with quarterly earnings of $0.22 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.21 per share a year ago. These figures are adjusted

Dine Brands (DIN) Beats Q2 Earnings and Revenue Estimates
Dine Brands (DIN) Beats Q2 Earnings and Revenue Estimates

Dine Brands (DIN) came out with quarterly earnings of $1.16 per share, beating the Zacks Consensus Estimate of $1.04 per share. This compares to earnings of $1.17 per share a year ago. These figures

Charles River Laboratories (CRL) Q2 Earnings and Revenues Surpass Estimates
Charles River Laboratories (CRL) Q2 Earnings and Revenues Surpass Estimates

Charles River Laboratories (CRL) came out with quarterly earnings of $3.02 per share, beating the Zacks Consensus Estimate of $2.72 per share. This compares to earnings of $3.12 per share a year

Brink's (BCO) Q2 Earnings and Revenues Surpass Estimates
Brink's (BCO) Q2 Earnings and Revenues Surpass Estimates

Brink's (BCO) came out with quarterly earnings of $2.13 per share, beating the Zacks Consensus Estimate of $2.05 per share. This compares to earnings of $1.79 per share a year ago. These figures are

BioCryst Pharmaceuticals (BCRX) Tops Q2 Earnings and Revenue EstimatesPhoto, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
BioCryst Pharmaceuticals (BCRX) Tops Q2 Earnings and Revenue Estimates

BioCryst Pharmaceuticals (BCRX) came out with quarterly earnings of $0.3 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.15 per share a year ago

Advantage Solutions Inc. (ADV) Reports Q2 Loss, Beats Revenue Estimates
Advantage Solutions Inc. (ADV) Reports Q2 Loss, Beats Revenue Estimates

Advantage Solutions Inc. (ADV) came out with a quarterly loss of $3.29 per share versus the Zacks Consensus Estimate of $1.51. This compares to a loss of $0.75 per share a year ago. These figures

Astec Industries (ASTE) Q2 Earnings Miss Estimates
Astec Industries (ASTE) Q2 Earnings Miss Estimates

Astec Industries (ASTE) came out with quarterly earnings of $0.94 per share, missing the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $0.88 per share a year ago. These

Looking for Consumer Staples Stocks? The Zacks Rank Can Help You Find Winners
Looking for Consumer Staples Stocks? The Zacks Rank Can Help You Find Winners

Building a successful investment portfolio takes skill and hard work, no matter if you're a growth, value, income, or momentum-focused investor.

But how do you find the right combination of stocks

Verano Holdings Corp. (VRNO) Reports Q2 Loss, Tops Revenue Estimates
Verano Holdings Corp. (VRNO) Reports Q2 Loss, Tops Revenue Estimates

Verano Holdings Corp. (VRNO) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to a loss of $0.25 per share a year ago. These

Orion Energy Systems, Inc. (OESX) Q1 Earnings and Revenues Surpass Estimates
Orion Energy Systems, Inc. (OESX) Q1 Earnings and Revenues Surpass Estimates

Orion Energy Systems, Inc. (OESX) came out with quarterly earnings of $0.47 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to a loss of $0.4 per share a

Urogen Pharma (URGN) Reports Q2 Loss, Tops Revenue EstimatesPhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png
Urogen Pharma (URGN) Reports Q2 Loss, Tops Revenue Estimates

Urogen Pharma (URGN) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to a loss of $1.05 per share a year ago. These figures

Southwest Gas (SWX) Lags Q2 Earnings and Revenue Estimates
Southwest Gas (SWX) Lags Q2 Earnings and Revenue Estimates

Southwest Gas (SWX) came out with quarterly earnings of $0.45 per share, missing the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.53 per share a year ago. These

One Stop Systems, Inc. (OSS) Reports Q2 Loss, Beats Revenue Estimates
One Stop Systems, Inc. (OSS) Reports Q2 Loss, Beats Revenue Estimates

One Stop Systems, Inc. (OSS) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.07 per share a year ago. These

NNN REIT (NNN) Q2 FFO Top Estimates
NNN REIT (NNN) Q2 FFO Top Estimates

NNN REIT (NNN) came out with quarterly funds from operations (FFO) of $0.9 per share, beating the Zacks Consensus Estimate of $0.89 per share. This compares to FFO of $0.85 per share a year ago